TY - JOUR
T1 - Pharmacists and the opioid crisis
T2 - A narrative review of pharmacists' practice roles
AU - Bratberg, Jeffrey P.
AU - Smothers, Zachary P.W.
AU - Collins, Kathryn
AU - Erstad, Brian
AU - Ruiz Veve, Jennifer
AU - Muzyk, Andrew J.
N1 - Publisher Copyright:
© 2019 Pharmacotherapy Publications, Inc.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Introduction: Nearly 2.5 million Americans have an opioid use disorder (OUD) related to prescription and/or illicit opioids. Pharmacists, as one of the most accessible care providers, are essential in mitigating the mortality and morbidity of the opioid overdose crisis. Pharmacists are involved in numerous care activities related to this crisis and to caring for patients with an OUD. Objective: The objective of this paper was to conduct a literature review to highlight several pharmacist-driven practices that provide a broad range of prevention, harm reduction, treatment, and recovery services to patients affected or potentially affected by the opioid crisis. Methods: Articles had to meet the criteria of describing pharmacist-led practice related to providing care to patients at risk of an opioid overdose, with an OUD, or related to opioid safety. The literature search was conducted in 2018 and utilized numerous sources including: OneSearch (EBSCOhost), PubMed, ScienceDirect, and the Journal of the American Pharmacists Association Opioid Topic Collection. Results: Seven articles were chosen for inclusion in this review. These studies report on innovative programs and practices that describe the role of pharmacists in the opioid crisis. Studies demonstrate the types of involvement pharmacists have in caring for patients throughout the care continuum: actively engaged in upstream interventions aimed at preventing misuse and improve safety; screening and monitoring opioid prescribing and usage; providing access to naloxone; and, assisting in the recovery and rehabilitation process of patients with OUD, including collaboratively managing OUD with evidence-based pharmacotherapy. Conclusion: The studies included in our narrative review demonstrate how innovative programs and practices can expand the role of pharmacists throughout the entire spectrum of interventions applied to the opioid crisis by capitalizing on their existing skill sets and knowledge.
AB - Introduction: Nearly 2.5 million Americans have an opioid use disorder (OUD) related to prescription and/or illicit opioids. Pharmacists, as one of the most accessible care providers, are essential in mitigating the mortality and morbidity of the opioid overdose crisis. Pharmacists are involved in numerous care activities related to this crisis and to caring for patients with an OUD. Objective: The objective of this paper was to conduct a literature review to highlight several pharmacist-driven practices that provide a broad range of prevention, harm reduction, treatment, and recovery services to patients affected or potentially affected by the opioid crisis. Methods: Articles had to meet the criteria of describing pharmacist-led practice related to providing care to patients at risk of an opioid overdose, with an OUD, or related to opioid safety. The literature search was conducted in 2018 and utilized numerous sources including: OneSearch (EBSCOhost), PubMed, ScienceDirect, and the Journal of the American Pharmacists Association Opioid Topic Collection. Results: Seven articles were chosen for inclusion in this review. These studies report on innovative programs and practices that describe the role of pharmacists in the opioid crisis. Studies demonstrate the types of involvement pharmacists have in caring for patients throughout the care continuum: actively engaged in upstream interventions aimed at preventing misuse and improve safety; screening and monitoring opioid prescribing and usage; providing access to naloxone; and, assisting in the recovery and rehabilitation process of patients with OUD, including collaboratively managing OUD with evidence-based pharmacotherapy. Conclusion: The studies included in our narrative review demonstrate how innovative programs and practices can expand the role of pharmacists throughout the entire spectrum of interventions applied to the opioid crisis by capitalizing on their existing skill sets and knowledge.
KW - buprenorphine
KW - naloxone
KW - naltrexone
KW - opioids
UR - http://www.scopus.com/inward/record.url?scp=85076241849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076241849&partnerID=8YFLogxK
U2 - 10.1002/jac5.1171
DO - 10.1002/jac5.1171
M3 - Review article
AN - SCOPUS:85076241849
SN - 2574-9870
VL - 3
SP - 478
EP - 484
JO - JACCP Journal of the American College of Clinical Pharmacy
JF - JACCP Journal of the American College of Clinical Pharmacy
IS - 2
ER -